Ansbert Gadicke, Director, 10% Owner at Cullinan Oncology, Inc. (CGEM), sold 6,680 shares at $29.06 ($194K) on 2021-09-16, disclosed to the SEC on 2021-09-20.
Open-market sale of $194k CGEM by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.06 | 432 | $13K | 6.5% |
| 2 | $29.06 | 3,124 | $91K | 46.8% |
| 3 | $29.06 | 3,124 | $91K | 46.8% |
| Total | $29.06 avg | 6,680 | $194K | 100% |
| Filing → |
| ITOS | SELL | 2022-01-06 | $20.9M | — | Filing → |
| ITOS | SELL | 2021-10-14 | $5.2M | — | Filing → |
| ITOS | SELL | 2021-10-05 | $2.2M | — | Filing → |